Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers
Abstract Alzheimer’s disease (AD) and related tauopathies are associated with pathological tau protein aggregation, which plays an important role in neurofibrillary degeneration and dementia. Targeted immunotherapy to eliminate pathological tau aggregates is known to improve cognitive deficits in AD...
| Published in: | npj Vaccines |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-06-01
|
| Online Access: | https://doi.org/10.1038/s41541-024-00904-1 |
